Cheryl A. Moertel

Papers

Total Citations

391

H-Index

About

Cheryl A. Moertel is a distinguished cytogeneticist whose pioneering work has fundamentally shaped our understanding of cancer genetics and prenatal diagnostics. Her landmark study, "A cytogenetic study of 53 human gliomas" (1989, 247 citations), provided one of the earliest comprehensive chromosomal analyses of malignant brain tumors, identifying key genetic aberrations that continue to inform neuro-oncology research. Moertel further advanced cancer cytogenetics through her characterization of renal oncocytomas and chromophobe cell renal carcinoma (1992, 123 citations), establishing critical chromosomal markers for distinguishing these kidney tumor subtypes. In prenatal genetics, she conducted a rigorous prospective study of 4,309 amniotic fluid specimens (1992), testing definitions for maternal cell contamination, true mosaicism, and pseudomosaicism using in situ culture and robotic harvesting—a methodological contribution that enhanced diagnostic accuracy in clinical cytogenetics. Her work bridges fundamental cancer biology and applied prenatal diagnostics, demonstrating how chromosomal analysis can illuminate disease mechanisms while improving patient care. With over 390 citations across her most influential papers, Moertel's research remains essential reading for geneticists, oncologists, and prenatal diagnosticians alike.